Back to search
FDAFDA · Food and drugs·Recall number D-0148-2020

PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25

Published October 30, 2019 · Recall initiated: October 9, 2019

Summary

FDA records drug Class II recall D-0148-2020, published October 30, 2019 and initiated October 9, 2019. Recalling firm: Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center; Status: Terminated; Reported quantity: 1370 bags; Lot: Lots: FB9014A Exp. 12/09/2019; FB9017A Exp. 12/16/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GMP Deviations: potential glass contamination

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Distributor
Nationwide.
Lot
Lots: FB9014A Exp. 12/09/2019; FB9017A Exp. 12/16/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25 recalled?

Yes. FDA published recall D-0148-2020 on October 30, 2019. Reported hazard: GMP Deviations: potential glass contamination

What should I do if I have this product?

Voluntary: Firm initiated · Letter